Derivative exercise or conversion — not an open-market buy.
Traded Aug 13, 2026 · Filed Aug 14, 2026
Ryan Specialty's & CHRO sold $86K of Ryan Specialty shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$86,344
Shares × reported transaction price
14 days after results of Jul 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.4% | −1.2% | +7.6% |
| 30 days | −3.3% | −2.4% | −0.9% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Ryan Specialty's Co-President and CRO sold $1.62M of Ryan Specialty shares. Nobody planned it ahead of time.